Antidiabetic potential of a long-acting derivative of GIP following once daily administration in type 2 diabetes.

V.A. Gault, N. Irwin, F.P.M. O'Harte, Brian Green, P.R. Flatt

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)P20
Number of pages1
JournalRegulatory Peptides
Volume122
Publication statusPublished - 2004

Cite this